These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3595612)

  • 1. Fractionation and identification of metaphase-specific phosphorylated forms of high-mobility-group proteins.
    Lund T; Skålhegg BS; Holtlund J; Blomhoff HK; Laland SG
    Eur J Biochem; 1987 Jul; 166(1):21-6. PubMed ID: 3595612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for complete separation of the high mobility group (HMG) proteins HMG I and HMG Y from HMG 14 and HMG 17 and a procedure for purification of HMG I and HMG Y.
    Lund T; Holtlund J; Skålhegg B; Laland SG
    J Chromatogr; 1986 Nov; 369(2):341-8. PubMed ID: 3805203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaphase-specific phosphorylations weaken the association between chromosomal proteins HMG 14 and 17, and DNA.
    Lund T; Berg K
    FEBS Lett; 1991 Sep; 289(1):113-6. PubMed ID: 1893999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells.
    Lund T; Holtlund J; Laland SG
    FEBS Lett; 1985 Jan; 180(2):275-9. PubMed ID: 3881281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metaphase specific phosphorylation of HMG I.
    Lund T; Laland SG
    Biochem Biophys Res Commun; 1990 Aug; 171(1):342-7. PubMed ID: 2168176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, highly phosphorylated protein, of the high-mobility group type, present in a variety of proliferating and non-proliferating mammalian cells.
    Ostvold AC; Holtlund J; Laland SG
    Eur J Biochem; 1985 Dec; 153(3):469-75. PubMed ID: 3000779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that high mobility group protein 17 is not phosphorylated in human colon carcinoma cells.
    Chapekar MS; Bustin M; Glazer RI
    Biochim Biophys Acta; 1985 Mar; 838(3):351-4. PubMed ID: 3882153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I.
    Elton TS; Reeves R
    Anal Biochem; 1986 Aug; 157(1):53-62. PubMed ID: 3464222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-step preparative method for separating SER 6-phosphorylated HMG 14 from unphosphorylated HMG 14 and in vitro phosphorylation reaction components.
    Bofinger DP; Fucile NW; Spaulding SW
    Anal Biochem; 1988 Apr; 170(1):9-18. PubMed ID: 2839054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein.
    Giancotti V; Bandiera A; Buratti E; Fusco A; Marzari R; Coles B; Goodwin GH
    Eur J Biochem; 1991 May; 198(1):211-6. PubMed ID: 2040281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the presence of two new high mobility group-like proteins in HeLa S3 cells.
    Lund T; Holtlund J; Fredriksen M; Laland SG
    FEBS Lett; 1983 Feb; 152(2):163-7. PubMed ID: 6297996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase.
    Meijer L; Ostvold AC; Walass SI; Lund T; Laland SG
    Eur J Biochem; 1991 Mar; 196(3):557-67. PubMed ID: 2013279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oxidation on the reverse-phase high-performance liquid chromatography characteristics of the high mobility groups 1 and 2 proteins.
    Elton TS; Reeves R
    Anal Biochem; 1985 Sep; 149(2):316-21. PubMed ID: 4073490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography.
    Elton TS; Reeves R
    Anal Biochem; 1985 Feb; 144(2):403-16. PubMed ID: 3993906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is high mobility group protein 17 phosphorylated in vivo? Re-examination of the HeLa cell cycle data.
    Bhorjee JS; Mellon I; Kifle L
    Biochem Biophys Res Commun; 1983 Mar; 111(3):1001-7. PubMed ID: 6220712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation by high-performance liquid chromatography of the low-molecular-mass high-mobility-group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus transformed cells.
    Goodwin GH; Cockerill PN; Kellam S; Wright CA
    Eur J Biochem; 1985 May; 149(1):47-51. PubMed ID: 2986970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease in low-Mr HMG proteins HMG I and HMG Y during differentiation of mouse teratocarcinoma cells.
    Vartiainen E; Palvimo J; Mahonen A; Linnala-Kankkunen A; Mäenpää PH
    FEBS Lett; 1988 Feb; 228(1):45-8. PubMed ID: 3342876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain.
    Chou DK; Evans JE; Jungalwala FB
    J Neurochem; 2001 Apr; 77(1):120-31. PubMed ID: 11279268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptor proteins for (ADP-ribose)n in the HeLa S3 cell cycle.
    Tanuma S; Kawashima K; Endo H
    J Biochem; 1986 Mar; 99(3):915-22. PubMed ID: 3711048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity.
    Reeves R; Langan TA; Nissen MS
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1671-5. PubMed ID: 2000376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.